We are live on ! Find out more
FULC icon

Fulcrum Therapeutics

81 hedge funds and large institutions have $250M invested in Fulcrum Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more call options, than puts

Call options by funds: $3.1M | Put options by funds: $1.24M

37% more capital invested

Capital invested by funds: $183M → $250M (+$67.2M)

1.33% more ownership

Funds ownership: 89.89%91.22% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 8881 (-7)

29% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 21

35% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 26

Holders
81
Holders Change
-7
Holders Change %
-7.95%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
17
Reduced
26
Closed
21
Calls
$3.1M
Puts
$1.24M
Net Calls
+$1.86M
Net Calls Change
-$36K
Name Holding Trade Value Shares
Change
Change in
Stake
Nisa Investment Advisors
76
Nisa Investment Advisors
Missouri
$6.85K
SPIA
77
Steward Partners Investment Advisory
New York
$3.51K
National Bank of Canada
78
National Bank of Canada
Quebec, Canada
$1.86K
Wells Fargo
79
Wells Fargo
California
$1.6K -$2.64K -604 -63%
Daiwa Securities Group
80
Daiwa Securities Group
Japan
$1K
Point72 Asset Management
81
Point72 Asset Management
Connecticut
-$6.27M -1,899,968 Closed
WP
82
Woodline Partners
California
-$1.97M -596,695 Closed
HMC
83
Harvard Management Company
Massachusetts
-$1.13M -341,972 Closed
Barclays
84
Barclays
United Kingdom
-$478K -144,983 Closed
OM
85
Opaleye Management
Massachusetts
-$474K -143,600 Closed
State of Wisconsin Investment Board
86
State of Wisconsin Investment Board
Wisconsin
-$386K -117,000 Closed
YIH
87
Y-Intercept (HK)
Hong Kong
-$203K -61,587 Closed
E
88
Ergoteles
New York
-$135K -40,800 Closed
LCM
89
Laurion Capital Management
New York
-$111K -33,645 Closed
MFS
90
Mirabella Financial Services
United Kingdom
-$108K -32,760 Closed
PMEF
91
Point72 Middle East FZE
United Arab Emirates
-$106K -32,145 Closed
UBS AM
92
UBS AM
Illinois
-$73.2K -25,699 Closed
OMC
93
Old Mission Capital
Illinois
-$78.9K -23,900 Closed
SFI
94
Susquehanna Fundamental Investments
Pennsylvania
-$74.6K -22,594 Closed
NCM
95
Nantahala Capital Management
Connecticut
-$70.5K -21,370 Closed
QT
96
Quantamental Technologies
New York
-$39.1K -11,855 Closed
PCM
97
Prelude Capital Management
New York
-$36.9K -11,171 Closed
Balyasny Asset Management
98
Balyasny Asset Management
Illinois
-$36.6K -11,087 Closed
DS
99
DRW Securities
Illinois
-$36K -11,000 Closed
New York State Common Retirement Fund
100
New York State Common Retirement Fund
New York
-$1.24K -376 Closed

FULC Hedge Fund Activity: Q3 2023 in Review

81 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q3 2023, worth a combined $250M — up 37% from $183M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of FULC and 15 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 17 added.

The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $6.26M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $6.27M sold.

  • 81 institutional investors held Fulcrum Therapeutics (FULC) as of Q3 2023, down from 88 in Q2 2023.
  • Funds reported $250M of Fulcrum Therapeutics stock for Q3 2023, up 37% quarter-over-quarter.
  • 15 funds opened new Fulcrum Therapeutics positions in Q3 2023 and 21 closed out, a net change of -6 holders.
  • The largest Fulcrum Therapeutics buyer in Q3 2023 was Jefferies Financial Group, an estimated $6.26M added.
  • The largest Fulcrum Therapeutics seller in Q3 2023 was Point72 Asset Management, an estimated $6.27M sold.

Based on aggregated 13F filings for Q3 2023.